| Product Code: ETC6189484 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The psoriasis market in Australia is well-established and continues to grow steadily, bolstered by increased diagnosis rates, patient awareness, and the availability of innovative therapies. Biologics and advanced systemic treatments are gaining traction, improving patient outcomes and quality of life. However, access to biologics may be limited by cost and healthcare coverage restrictions. Ongoing research, patient support programs, and evolving reimbursement policies are expected to shape the market`s trajectory positively.
The psoriasis treatment market in Australia is witnessing substantial transformation with the rising availability and adoption of biologic therapies and personalized medicine. Increasing diagnosis rates and public awareness initiatives are reducing stigma and encouraging treatment. Trends also show a growing patient preference for topical and oral treatments that provide ease of use. The expansion of teledermatology services post-pandemic has improved access, particularly in remote regions. Moreover, the presence of active clinical trials and pharmaceutical investments is making Australia a key market for innovative psoriasis therapeutics.
The Australia Psoriasis Market faces several challenges, including the high prevalence of the disease, which puts a strain on healthcare resources and drives demand for more effective and accessible treatments. Despite the availability of treatment options, many patients do not respond well to existing therapies, leading to a need for innovative treatments. Moreover, the high cost of biologic drugs and topical therapies, coupled with issues of insurance coverage and patient access, remains a significant barrier. There is also the challenge of addressing the psychosocial impact of psoriasis, as the visible nature of the disease can lead to stigmatization and affect quality of life for many patients.
Australia psoriasis market is one of the more mature dermatology segments but still presents lucrative investment potential, especially with the advent of next-generation biologics and personalized medicine. Opportunities exist in biosimilars, digital dermatology platforms, and patient engagement apps. Investors can also explore topical cannabinoid-based treatments, a growing trend in alternative dermatology care in Australia.
Psoriasis treatment is well supported by the PBS, particularly for biologic therapies. The government also promotes equitable access to dermatology services via public hospitals and telehealth. Awareness campaigns and funding through the NHMRC support ongoing research into psoriasis pathophysiology and new treatment modalities.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Psoriasis Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Psoriasis Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Psoriasis Market - Industry Life Cycle |
3.4 Australia Psoriasis Market - Porter's Five Forces |
3.5 Australia Psoriasis Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Australia Psoriasis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Australia Psoriasis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Australia Psoriasis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Australia Psoriasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Psoriasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psoriasis in Australia |
4.2.2 Growing awareness about psoriasis and its treatment options |
4.2.3 Advancements in medical research leading to new and more effective treatment options |
4.3 Market Restraints |
4.3.1 High cost of psoriasis treatments |
4.3.2 Limited access to specialized healthcare providers for psoriasis management |
4.3.3 Side effects associated with certain psoriasis medications |
5 Australia Psoriasis Market Trends |
6 Australia Psoriasis Market, By Types |
6.1 Australia Psoriasis Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Australia Psoriasis Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Australia Psoriasis Market Revenues & Volume, By Nail Psoriasis, 2021- 2031F |
6.1.4 Australia Psoriasis Market Revenues & Volume, By Guttate Psoriasis, 2021- 2031F |
6.1.5 Australia Psoriasis Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.2 Australia Psoriasis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Australia Psoriasis Market Revenues & Volume, By Tumour necrosis factor inhibitors, 2021- 2031F |
6.2.3 Australia Psoriasis Market Revenues & Volume, By Vitamin D analogues, 2021- 2031F |
6.2.4 Australia Psoriasis Market Revenues & Volume, By Interleukin-inhibitors, 2021- 2031F |
6.3 Australia Psoriasis Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Australia Psoriasis Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.3.3 Australia Psoriasis Market Revenues & Volume, By Skin Biopsy, 2021- 2031F |
6.4 Australia Psoriasis Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Australia Psoriasis Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Australia Psoriasis Market Revenues & Volume, By Topical, 2021- 2031F |
6.5 Australia Psoriasis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Australia Psoriasis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Australia Psoriasis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Australia Psoriasis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Australia Psoriasis Market Import-Export Trade Statistics |
7.1 Australia Psoriasis Market Export to Major Countries |
7.2 Australia Psoriasis Market Imports from Major Countries |
8 Australia Psoriasis Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed psoriasis treatment plans |
8.2 Number of clinical trials for new psoriasis treatments in Australia |
8.3 Percentage of healthcare providers trained in psoriasis management |
9 Australia Psoriasis Market - Opportunity Assessment |
9.1 Australia Psoriasis Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Australia Psoriasis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Australia Psoriasis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Australia Psoriasis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Australia Psoriasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Psoriasis Market - Competitive Landscape |
10.1 Australia Psoriasis Market Revenue Share, By Companies, 2024 |
10.2 Australia Psoriasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here